DarzalexДаратумумаб1800oneBottleJanssen Darzalex® is prescribed: \r\n in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation; \r\n as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose previous therapy included a proteasome inhibitor and an immunomodulatory agent and who had disease progression during the last therapy; \r\n as part of combination therapy with lenalidomide and dexamethasone or bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one line of thera...
in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation;
as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose previous therapy included a proteasome inhibitor and an immunomodulatory agent and who had disease progression during the last therapy;
as part of combination therapy with lenalidomide and dexamethasone or bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one line of therapy.
